Fundz

OneSource Pharma to merge with Steriscience group

Feb 26, 2026

Acquiring Company

OneSource Specialty Pharma

Acquired Company

Steriscience group entities

KarnatakaIndiaManufacturingBiotechnologyPharmaceuticalManufacturingBiotechnologyPharmaceutical

Description

OneSource Specialty Pharma Limited has secured necessary 'No Objection' letters from the NSE and BSE for its proposed merger with Steriscience group entities. This marks a crucial step in the company's consolidation efforts. The letters were issued on February 25, 2026, paving the way for further regulatory approvals. The merger aims to integrate multiple entities into OneSource, improving market position and operational efficiency.

Who to call at OneSource Specialty Pharma, and when

When OneSource Specialty Pharma changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day OneSource Specialty Pharma raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at OneSource Specialty Pharma, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at OneSource Specialty Pharma. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

OneSource Specialty Pharma

Location

Karnataka, India

About

OneSource Specialty Pharma is a multi-modality specialty pharma company acting as a pure-play contract development and manufacturing organization (CDMO). They focus on integrated Drug Substance and Drug Product (DS/DP) manufacturing. Their goal is to accelerate regulatory approvals and drive access to innovative biologics. OneSource's facility is located in Bengaluru.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment OneSource Specialty Pharma makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for OneSource Specialty Pharma's next move

Learn about Strategic plan

Frequently asked

Who acquired Steriscience group entities?

Steriscience group entities was acquired by OneSource Specialty Pharma, based in Karnataka. The deal was reported on February 26, 2026. OneSource Specialty Pharma is a multi-modality specialty pharma company acting as a pure-play contract development and manufacturing organization (CDMO). OneSource Specialty Pharma is privately held and operates in Manufacturing.

When did OneSource Specialty Pharma acquire Steriscience group entities?

OneSource Specialty Pharma's acquisition of Steriscience group entities was reported on February 26, 2026. OneSource Specialty Pharma Limited has secured necessary 'No Objection' letters from the NSE and BSE for its proposed merger with Steriscience group entities. This marks a crucial step in the company's consolidation efforts. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Steriscience group entities do?

Steriscience group entities include various companies involved in the manufacturing of pharmaceutical products, particularly injectables and anti-infectives. The group includes Steriscience Specialties Private Limited and Brooks Steriscience Limited. It is privately held, operating in Manufacturing, and is based in India.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.